| __timestamp | Lantheus Holdings, Inc. | Ligand Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 72429000 | 22570000 |
| Thursday, January 1, 2015 | 78634000 | 24378000 |
| Friday, January 1, 2016 | 75374000 | 26621000 |
| Sunday, January 1, 2017 | 92157000 | 28653000 |
| Monday, January 1, 2018 | 93326000 | 37734000 |
| Tuesday, January 1, 2019 | 103132000 | 41884000 |
| Wednesday, January 1, 2020 | 110171000 | 64435000 |
| Friday, January 1, 2021 | 218817000 | 57483000 |
| Saturday, January 1, 2022 | 233827000 | 70062000 |
| Sunday, January 1, 2023 | 267194000 | 52790000 |
Unleashing the power of data
In the ever-evolving landscape of pharmaceuticals, operational efficiency is paramount. Over the past decade, Lantheus Holdings, Inc. and Ligand Pharmaceuticals Incorporated have showcased contrasting trends in their Selling, General, and Administrative (SG&A) expenses.
Lantheus has seen a remarkable increase in SG&A expenses, growing by approximately 270% from 2014 to 2023. This surge reflects their aggressive expansion and investment in operational capabilities. Notably, the year 2021 marked a significant leap, with expenses nearly doubling from the previous year, indicating strategic shifts or expansions.
Conversely, Ligand's SG&A expenses have remained relatively stable, with a modest increase of about 130% over the same period. This steadiness suggests a more conservative approach, focusing on maintaining operational efficiency while navigating the competitive pharmaceutical market.
These insights into SG&A trends offer a glimpse into the strategic priorities of these two industry players.
Who Optimizes SG&A Costs Better? Merck & Co., Inc. or Lantheus Holdings, Inc.
Breaking Down SG&A Expenses: United Therapeutics Corporation vs Lantheus Holdings, Inc.
Cost Management Insights: SG&A Expenses for Genmab A/S and Ligand Pharmaceuticals Incorporated
Jazz Pharmaceuticals plc and Ligand Pharmaceuticals Incorporated: SG&A Spending Patterns Compared
Who Optimizes SG&A Costs Better? Halozyme Therapeutics, Inc. or Ligand Pharmaceuticals Incorporated
Selling, General, and Administrative Costs: Lantheus Holdings, Inc. vs Cytokinetics, Incorporated
Cost Management Insights: SG&A Expenses for Lantheus Holdings, Inc. and Corcept Therapeutics Incorporated
Selling, General, and Administrative Costs: Lantheus Holdings, Inc. vs PTC Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for Lantheus Holdings, Inc. and Perrigo Company plc
Who Optimizes SG&A Costs Better? Lantheus Holdings, Inc. or Taro Pharmaceutical Industries Ltd.
Comparing SG&A Expenses: Lantheus Holdings, Inc. vs Celldex Therapeutics, Inc. Trends and Insights
Ligand Pharmaceuticals Incorporated vs Dynavax Technologies Corporation: SG&A Expense Trends